| 发明名称 | Methods involving aldose reductase inhibitors | ||
| 摘要 | Embodiments of the invention include methods and compositions involving aldose reductase inhibitors for the treatment of inflammation, including uveitis and asthma. | ||
| 申请公布号 | US9186362(B2) | 申请公布日期 | 2015.11.17 |
| 申请号 | US201213546009 | 申请日期 | 2012.07.11 |
| 申请人 | The Board of Regents of the University of Texas System | 发明人 | Srivastava Satish K.;Ramana Kota V. |
| 分类号 | A61K31/50;A61K31/538;A61K31/4188;A61K31/502;A61K31/535;A61K31/4164;A61K31/4166;A61K31/499;C12N15/113 | 主分类号 | A61K31/50 |
| 代理机构 | Norton Rose Fulbright US LLP | 代理人 | Norton Rose Fulbright US LLP |
| 主权项 | 1. A method of treating uveitis in a non-diabetic subject comprising: administering to a non-diabetic subject an amount of a pharmaceutically acceptable composition comprising an aldose reductase inhibitor selected from epalrestat, ponalrestat, risarestat, imirestat, zoplrestat, minalrestat AS-3201 (ranirestat) tolrestat, or fidarestat to treat uveitis. | ||
| 地址 | Austin TX US | ||